Top compounds associated with response to LRRC37B


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA decitabine CTRPv2 pan-cancer AAC 0.15 2e-07
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.17 9e-07
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
Download CSV